Success Metrics

Clinical Success Rate
93.9%

Based on 31 completed trials

Completion Rate
94%(31/33)
Active Trials
16(28%)
Results Posted
6%(2 trials)
Terminated
2(3%)

Phase Distribution

Ph not_applicable
22
38%
Ph phase_3
1
2%
Ph early_phase_1
1
2%
Ph phase_4
1
2%

Phase Distribution

1

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution25 total trials
Early Phase 1First-in-human
1(4.0%)
Phase 3Large-scale testing
1(4.0%)
Phase 4Post-market surveillance
1(4.0%)
N/ANon-phased studies
22(88.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.6%

31 of 35 finished

Non-Completion Rate

11.4%

4 ended early

Currently Active

16

trials recruiting

Total Trials

58

all time

Status Distribution
Active(21)
Completed(31)
Terminated(4)
Other(2)

Detailed Status

Completed31
Recruiting12
Not yet recruiting5
Active, not recruiting4
Terminated2
unknown2

Development Timeline

Analytics

Development Status

Total Trials
58
Active
16
Success Rate
93.9%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (4.0%)
Phase 31 (4.0%)
Phase 41 (4.0%)
N/A22 (88.0%)

Trials by Status

terminated23%
active_not_recruiting47%
recruiting1221%
completed3153%
not_yet_recruiting59%
unknown23%
withdrawn23%

Recent Activity

Clinical Trials (58)

Showing 20 of 58 trialsScroll for more
NCT06033248

Using Urine Samples to Identify Lung Cancer

Recruiting
NCT05458622Phase 3

3TR (Taxonomy, Treatment, Targets and Remission) Systemic Lupus Erithematosus Study Protocol

Active Not Recruiting
NCT05747651

3TR (Taxonomy, Treatment, Targets and Remission) Systemic Lupus Erythematosus Study Protocol 2

Completed
NCT06820450

Pilot Study to Characterize the Endometriosis Steroidome and Its Link to Endocrine Disruptors and Vaginal Dysbiosis

Recruiting
NCT03575156Not Applicable

Microparticles's Role in the Pathophysiology of Systemic Lupus Erythematosus and Systemic Sclerosis

Completed
NCT03421184Not Applicable

Dietary Phytoestrogens as Risk Factors for Systemic Lupus Erythematosus

Completed
NCT04874909Not Applicable

Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM)

Completed
NCT07564752

The Effect of Improved Glycemic Control on the Composition and Function of High-Density Lipoproteins (HDL) in Patients With Type 1 Diabetes

Recruiting
NCT07545174Not Applicable

Role of the Environment in Pediatric Obesity

Not Yet Recruiting
NCT05754892Not Applicable

Positioning of Molecular Markers in Clinical Routine for the Management of Patients With Adrenal Cancers/Tumors (COMETE-CARE)

Recruiting
NCT07328464

Occupational Exposure to Antineoplastic Drugs Among Physiotherapists in Healthcare Settings

Not Yet Recruiting
NCT07205913

Gut Microbiota, Diet-INDuced Obesity and Type 2 Diabetes in New Caledonia - MIND

Not Yet Recruiting
NCT06854848

Cohort of Patients With Systemic Granulomatosis and Associated Biological Collection

Recruiting
NCT05997784

Study of Indoor Air Pollutants and Their Impact in Childhood Health and Wellbeing

Active Not Recruiting
NCT07203131Not Applicable

Evaluation of the Impact of an Alteration of NAD+ Metabolism on the Renal Prognosis of Patients Admitted to Intensive Care (NI-AKI)

Recruiting
NCT01351961Not Applicable

Vascular Alteration and Evolution of Cognitive Impairment

Completed
NCT03947346

Biomarkers of Renal Dysfunction in Neuroblastoma Survivors

Completed
NCT03698071Not Applicable

Soluble CD95 Ligand Role in the Pathophysiology of Antineutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis

Completed
NCT06945822Not Applicable

Characterizing the Host Response to Leptospirosis for Better Diagnosis and Prognosis - NIHFI

Not Yet Recruiting
NCT06914778

Investigating the Metabolic and Lipidomic Profiles That Are Associated With Varying Grades of Diabetic Maculopathy and Retinopathy in South Wales

Recruiting

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
58